QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

As previously disclosed, on September 21, 2023, Oramed Pharmaceuticals Inc. (the "Company") entered into and consummate...

 oramed-pharmaceuticals-extends-stock-buyback-program-for-one-year

-SEC Filing

Core News & Articles

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

 oramed-pharmaceuticals-issues-letter-to-shareholders-from-president-and-ceo-nadav-kidron

Dear Shareholders,I am happy to take this opportunity to provide our shareholders with an overview of our key accomplishments a...

Core News & Articles

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))), an innovative revenue-generating company foc...

Core News & Articles

Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. ("Oramed"), are expected...

 hc-wainwright--co-reiterates-neutral-on-oramed-pharmaceuticals

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oramed Pharmaceuticals (NASDAQ:ORMP) with a Neutral.

 hc-wainwright--co-reiterates-neutral-on-oramed-pharmaceuticals

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oramed Pharmaceuticals (NASDAQ:ORMP) with a Neutral.

Core News & Articles

David will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.

 top-4-health-care-stocks-that-may-crash-this-quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a...

Core News & Articles

An initial principal balance of $101,875,000.00; A senior lien for Oramed on substantially all assets of Scilex and its subs...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION